Work

HSR25-156: Myelosuppression and Healthcare Resource Utilization in Community Oncology Patients With Limited-Stage Small Cell Lung Cancer (LS-SCLC) Receiving First-Line Therapy With or Without Trilaciclib

Year: 2025

Type: article

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7175

Authors: Ajeet Gajra, Peter Reeves, Susan O'Brien, Anna Carey, Michelle Moore, Huan Huang

Institutions: Hematology Oncology Associates of Central New York, G1 Therapeutics (United States)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408958738

FWCI:

Cites:

Cited by:

Related to: 10